Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions

Neurofibromatosis Type 1

Interventions

OTHER

Whole-body Magnetic Resonance Imaging

Whole-body Magnetic Resonance Imaging at baseline, 1 month, and 12 months

Trial Locations (1)

RECRUITING

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors

lead

Nicole Baca

OTHER